Pennsylvania holds up Merck's off-label Vioxx marketing deal; Appeals court lets DEA suspend Cardinal facility;

@FiercePharma: Pharma opportunity: Figure out how to get women to adhere to scripts, and docs to prescribe to women on par with men. Article | Follow @FiercePharma

> A restitution claim from the state of Pennsylvania is holding up the final stage of Merck's ($MRK) $950 million Vioxx off-label marketing settlement with the Justice Department and more than 40 states. Article

> A U.S. appeals court allowed the Drug Enforcement Administration to suspend Cardinal Health's ability to ship controlled substances from a Florida facility that's under scrutiny. News

> Canadian veterinarians worry that a shortage of Sandoz animal drugs, caused by manufacturing problems at a Quebec plant, will affect their ability to perform surgery on pets. Report

> Australia's Sigma Pharmaceuticals asked Fair Work Australia to intervene in a strike that has interfered with distribution of some products. More

> The Obama administration said the free birth-control mandate would apply to self-insured Roman Catholic institutions, but would be administered by third-party claims companies. Story

Biotech News

@FierceBiotech: RNAi, smuggled in a virus, weakens tumors before final radiation blow. More | Follow @FierceBiotech

@JohnCFierce: Note to pessimists: Maybe the sky isn't falling. Thoughts on the VC apocalypse. Piece | Follow @JohnCFierce

@RyanMFierce: Versant Ventures has named Roche vet Guido Magni a venture partner to aid Euro life sciences practice. Release | Follow @RyanMFierce

@FierceMedDev: White House OKs medical device act. News | Follow @FierceMedDev

> At the threshold of PhIII, Neurologix heads into bankruptcy. News

> Cardiome whips out budget ax as Merck dumps oral heart drug pact. Article

> Anthera slashes jobs over failed cardiac trial, shifts focus to lupus drug. More

Medical Device News

> Kensey Nash, St. Jude wrap up Angio-Seal dispute. Article

> Akili envisions video game as therapeutic device. Item

> Covidien scoops up pulmonary devicemaker for $300M. News

Biotech IT News

> Stanford algorithm uncovers drug side effects. Story

> Biomatters taps Ammundsen as CEO. Item

> GSK strikes deal to listen in on social media chatter. Article

> Medidata lauded on Wall Street; CEO takes shot at rival Oracle. More

And Finally... The WHO will meet Wednesday to examine the evidence for "totally drug-resistant" tuberculosis. Report